Tearsheet

Investment Highlights

null
null

Market Valuation

 9/30/252024202320222021
Share Price CYE$18.00$0.75$2.70  
Market Cap CYE ($ Bil)0.0----
Total Debt ($ Bil)0.00.00.00.00.0
Total Cash ($ Bil)0.00.00.00.00.0
Enterprise Value ($ Bil)0.0    
Valuation Ratios     
P/S TTM0.00.20.70.00.0
P/EBIT TTM0.0-3.58.50.00.0
P/E TTM0.0-4.310.90.00.0
Sector Ratios     
P/S TTM (Sector)1.11.01.11.22.0
P/EBIT TTM (Sector)1.81.0-0.11.13.2
P/E TTM (Sector)-0.7-0.8-0.5-0.31.7
 9/30/2520242023
Share Price CYE$18.00$0.75$2.70
Market Cap CYE ($ Bil)0.0--
Total Debt ($ Bil)0.00.00.0
Total Cash ($ Bil)0.00.00.0
Enterprise Value ($ Bil)0.0  
Valuation Ratios   
P/S TTM0.00.20.7
P/EBIT TTM0.0-3.58.5
P/E TTM0.0-4.310.9
Sector Ratios   
P/S TTM (Sector)1.11.01.1
P/EBIT TTM (Sector)1.81.0-0.1
P/E TTM (Sector)-0.7-0.8-0.5

Business Description

Price Returns Compared

Expand for Detailed View

 202020212022202320242025Total [1]
Returns
APLM Return--4%-91%-90%89%-100%
Peers Return75%-16%-34%-21%-51%43%-47%
S&P 500 Return16%27%-19%24%23%13%106%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: VRTX, EDIT, INFIQ, SRNE, STA.
[3] 2025 data is for the year up to 9/29/2025 (YTD)

Trade Ideas

Select past trade ideas related to APLM and Biotechnology.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
LNTH_8312025_Dip_Buyer_High_CFO_Margins_ExInd_DE08312025LNTHLantheusDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-7.8%-7.8%-8.7%
COO_8312025_Monopoly_xInd_xCD_Getting_Cheaper08312025COOCooper CompaniesMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple
0.2%0.2%-4.6%
WST_8312025_Monopoly_xInd_xCD_Getting_Cheaper08312025WSTWest Pharmaceutical ServicesMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple
5.9%5.9%-1.3%
BMY_7312025_Dip_Buyer_FCFYield07312025BMYBristol-Myers SquibbDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
1.9%1.9%0.0%
UTHR_7312025_Dip_Buyer_FCFYield07312025UTHRUnited TherapeuticsDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
57.5%57.5%0.0%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
LNTH_8312025_Dip_Buyer_High_CFO_Margins_ExInd_DE08312025LNTHLantheusDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-7.8%-7.8%-8.7%
COO_8312025_Monopoly_xInd_xCD_Getting_Cheaper08312025COOCooper CompaniesMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple
0.2%0.2%-4.6%
WST_8312025_Monopoly_xInd_xCD_Getting_Cheaper08312025WSTWest Pharmaceutical ServicesMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple
5.9%5.9%-1.3%
BMY_7312025_Dip_Buyer_FCFYield07312025BMYBristol-Myers SquibbDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
1.9%1.9%0.0%
UTHR_7312025_Dip_Buyer_FCFYield07312025UTHRUnited TherapeuticsDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
57.5%57.5%0.0%

See Trefis Trade Ideas for more.

Recent Active Movers

Recent Active Movers

More From Trefis

Peer Comparisons for Apollomics

Financials

APLMVRTXEDITINFIQSRNESTAMedian
NameApollomi.Vertex P.Editas M.Infinity.Sorrento.Starton . 
Mkt Price-395.313.52---199.41
Mkt Cap-101.50.3---50.9
Rev LTM-11,41939--039
Op Inc LTM--199-161---11-161
FCF LTM-3,500-205---1,647
FCF 3Y Avg-1,984-182---901
CFO LTM-3,846-201---1,823
CFO 3Y Avg-2,324-177---1,073

Growth & Margins

APLMVRTXEDITINFIQSRNESTAMedian
NameApollomi.Vertex P.Editas M.Infinity.Sorrento.Starton . 
Rev Chg LTM-10.5%-42.0%----15.8%
Rev Chg 3Y Avg-11.0%55.3%---33.1%
Rev Chg Q-12.1%597.5%---304.8%
QoQ Delta Rev Chg LTM-2.9%8.6%---5.7%
Op Mgn LTM--1.7%-413.4%----207.5%
Op Mgn 3Y Avg-26.5%-616.5%----295.0%
QoQ Delta Op Mgn LTM-2.0%164.9%---83.5%
CFO/Rev LTM-33.7%-517.6%----242.0%
CFO/Rev 3Y Avg-22.5%-538.7%----258.1%
FCF/Rev LTM-30.6%-526.8%----248.1%
FCF/Rev 3Y Avg-19.2%-552.8%----266.8%

Valuation

APLMVRTXEDITINFIQSRNESTAMedian
NameApollomi.Vertex P.Editas M.Infinity.Sorrento.Starton . 
Mkt Cap-101.50.3---50.9
P/S-8.97.6---8.3
P/EBIT-23.1-1.3---10.9
P/E-27.9-1.3---13.3
P/CFO-26.4-1.5---12.5
Total Yield-3.6%-79.7%----38.1%
Dividend Yield-0.0%0.0%---0.0%
FCF Yield 3Y Avg-2.1%-61.3%----29.6%
D/E-0.00.1---0.0
Net D/E--0.0-0.5----0.3

Returns

APLMVRTXEDITINFIQSRNESTAMedian
NameApollomi.Vertex P.Editas M.Infinity.Sorrento.Starton . 
1M Rtn-1.1%37.0%---19.0%
3M Rtn--11.2%60.0%---24.4%
6M Rtn--18.5%203.4%---92.5%
12M Rtn--14.6%1.1%----6.7%
3Y Rtn-36.5%-71.2%----17.4%
1M Excs Rtn--1.6%30.4%---14.4%
3M Excs Rtn--18.6%52.6%---17.0%
6M Excs Rtn--39.1%162.2%---61.6%
12M Excs Rtn--30.8%-12.6%----21.7%
3Y Excs Rtn--39.2%-150.7%----95.0%

Financials

Short Interest

Short Interest: As Of Date9152025
Short Interest: Shares Quantity2,694
Short Interest: % Change Since 8312025-82.0%
Average Daily Volume66,186
Days-to-Cover Short Interest1

SEC Filings

Expand for More

Report DateFiling DateFiling
12312024403202520-F 12/31/2024
630202481420246-K 6/30/2024
12312023328202420-F 12/31/2023
630202392820236-K 6/30/2023
12312022428202320-F 12/31/2022
123120212282023DEFM14A 12/31/2021

Insider Activity

Expand for More